Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good point of support, start of climb?
I didn't mean to suggest you were. I merely replied to the most recent post.
This article does not apply to me I am not a promoter or in a publicity campaign, nor writing articles, and have never been paid or compensated otherwise by anyone.
Only a private individual using the board and doing my own stock research and discussing topics to other members.
Not sure why you sent me the link, but I am pleased to clarify any concerns. If you would prefer that I find another place to do my work, no problem please let me know and I will oblige.
That was a squeeze EOD Friday. SunTrust d/g today
* * $LBIO Video Chart 06-03-16 * *
Link to Video - click here to watch the technical chart video
Tutes should be loading after Jeffries Conference. > 12.00+ next week.
LBIO > to Present at the Jefferies 2016 Healthcare Conference
NEW YORK, NY--(Marketwired - June 03, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), announced today that Lion management will present a company overview at the upcoming Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 at 2:30pm E.T in New York, NY.
A live webcast of the presentation will be available by visiting the Investors section of Lion Biotechnologies' website at http://ir.lbio.com/. A replay of the webcast will be archived on Lion Biotechnologies' website for 30 days following the presentation.
About Lion Biotechnologies
Lion Biotechnologies, Inc. is a clinical-stage biotechnology company focused on the development of cancer immunotherapy products for the treatment of various cancers. The company's lead product candidate is an adoptive cell therapy using tumor-infiltrating lymphocytes (TILs) for the treatment of patients with refractory metastatic melanoma, and is based on a clinical Cooperative Research and Development Agreement with the National Cancer Institute. TIL therapy is also being evaluated in physician-sponsored clinical trials at MD Anderson Cancer Center and Moffitt Cancer Center. For more information, please visit http://www.lionbio.com.
LBIO > Lion Biotechnologies' stock rockets in active trade after receipt of $100 million investment
- DJNF
Shares of Lion Biotechnologies Inc. (LBIO) rocketed to a 10-month high Friday, on more than 50 times the daily average volume, after the biotechnology company said it raised $100 million in a private placement of shares. Volume was 9.1 million shares in afternoon trade, compared with the full-day average of about 180,000 shares over the past 30 days, according to FactSet. The company said early Friday it entered into agreements with institutional and other accredited investors to sell a total of 9.7 million common shares at $4.75 each, and 11.4 million Series B preferred non-voting shares, also at $4.75 each. The Series B shares will become convertible to one share of common stock. Separately, Lion said it named Maria Fardis as its Chief Executive, replacing Elma Hawkins, how had been CEO since January 2015. The stock was now up 8.3% year to date, while the S&P 500 has gained 2.8%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
June 03, 2016 15:24 ET (19:24 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
LBIO > Maria Fardis new CEO:
http://finance.yahoo.com/news/lion-biotechnologies-appoints-maria-fardis-133430905.html
Company picked up #1 CEO today! > Ton of catalysts at work here.
Company picked up #1 CEO today! > Ton of catalysts at work here.
LBIO 8.4 short ready. Based on $100m private placement at 4.75, which attracted shorts at $6. So they squeeze to $9
$LBIO recent news/filings
bearish 6.43
## source: finance.yahoo.com
Mon, 16 Nov 2015 18:59:03 GMT ~ Lion Biotechnologies to Participate in Upcoming Investor Conferences
[at noodls] - Released on November 16, 2015 NEW YORK, November 16, 2015 - Lion Biotechnologies, (Nasdaq: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes ...
read full: http://www.noodls.com/view/0E393424A098E28CD8CD36857E7F6C945CFC970E
*********************************************************
Mon, 16 Nov 2015 13:00:00 GMT ~ Lion Biotechnologies to Participate in Upcoming Investor Conferences
[GlobeNewswire] - NEW YORK -- Lion Biotechnologies, , a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that President and CEO Elma Hawkins, ...
read full: http://finance.yahoo.com/news/lion-biotechnologies-participate-upcoming-investor-130000451.html
*********************************************************
Fri, 13 Nov 2015 18:04:24 GMT ~ LION BIOTECHNOLOGIES, INC. Financials
read full: http://finance.yahoo.com/q/is?s=lbio
*********************************************************
Wed, 11 Nov 2015 22:16:11 GMT ~ Lion Biotechnologies Announces Agreement with WuXi AppTec to Increase TIL Manufacturing Capacity
[at noodls] - Released on November 11, 2015 NEW YORK, November 9, 2015 - Lion Biotechnologies, Inc. (Nasdaq: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating ...
read full: http://www.noodls.com/view/FBF994109024CD1500E583D85F776D196FA09423
*********************************************************
Mon, 09 Nov 2015 13:00:00 GMT ~ Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing Capacity
[GlobeNewswire] - NEW YORK -- Lion Biotechnologies, Inc. , a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that it has entered into ...
read full: http://finance.yahoo.com/news/lion-biotechnologies-announces-agreement-wuxi-130000074.html
*********************************************************
$LBIO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$LBIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/LBIO/company-info
Ticker: $LBIO
OTC Market Place: Not Available
CIK code: 0001425205
Company name: Lion Biotechnologies, Inc.
Company website: http://www.lionbio.com
Incorporated In: NV, USA
$LBIO share structure
## source: otcmarkets.com
Market Value: $305,180,499 a/o Nov 16, 2015
Shares Outstanding: 47,833,934 a/o Oct 31, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$LBIO extra dd links
Company name: Lion Biotechnologies, Inc.
Company website: http://www.lionbio.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=LBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=LBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=LBIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/news - http://finance.yahoo.com/q/h?s=LBIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/LBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=LBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/LBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Lion+Biotechnologies%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Lion+Biotechnologies%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Lion+Biotechnologies%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.lionbio.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.lionbio.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.lionbio.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/LBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001425205&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=LBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=LBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=LBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=LBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=LBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=LBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=LBIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/LBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=LBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/LBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=LBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/LBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/LBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/LBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=LBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=LBIO
$LBIO DD Notes ~ http://www.ddnotesmaker.com/LBIO
TPIV sure turned into being a dog..
Added more today.
I have a very hefty position here now
Yes
I agree
I've been buying the dips and I'm back to even at 9.77
Ready for some green now
One of the best stocks to own at the moment. Great opportunity.
LOS ANGELES, CA (June 24, 2015) – Lion Biotechnologies, Inc. (Nasdaq: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that it will join the Russell Global Index on June 26, according to a list of final additions posted June 19 on the FTSE Russell website.
Jumped back in here again on the dip today
LBIO uplisted to the Nasdaq:
http://otce.finra.org/DLDeletions
LBIO is great, but there is another immunotherapy that appears more portent and powerful:
http://bit.ly/cancerstockwinner
$LBIO recent news/filings
bullish
## source: finance.yahoo.com
Wed, 23 Jul 2014 12:00:00 GMT ~ Lion Biotechnologies Leases New Research Laboratory
[GlobeNewswire] - LOS ANGELES -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TILs), today announced that it has ...
read full: http://finance.yahoo.com/news/lion-biotechnologies-leases-research-laboratory-120000853.html
*********************************************************
Mon, 23 Jun 2014 12:00:00 GMT ~ Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer
[GlobeNewswire] - LOS ANGELES -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TILs), today announced that it has ...
read full: http://finance.yahoo.com/news/lion-biotechnologies-appoints-dr-laszlo-120000088.html
*********************************************************
Tue, 27 May 2014 12:00:00 GMT ~ Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference
[GlobeNewswire] - LOS ANGELES -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on tumor-infiltrating lymphocytes ...
read full: http://finance.yahoo.com/news/lion-biotechnologies-present-jefferies-2014-120000293.html
*********************************************************
Wed, 21 May 2014 16:18:38 GMT ~ LION BIOTECHNOLOGIES, INC. Financials
read full: http://finance.yahoo.com/q/is?s=lbio
*********************************************************
Mon, 19 May 2014 17:17:11 GMT ~ LION BIOTECHNOLOGIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
read full: http://biz.yahoo.com/e/140519/lbio8-k.html
*********************************************************
$LBIO charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$LBIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/LBIO/company-info
Ticker: $LBIO
OTC Market Place: OTCQB
CIK code: 0001425205
Company name: Lion Biotechnologies, Inc.
Company website: http://www.lionbio.com
Incorporated In: NV, USA
$LBIO share structure
## source: otcmarkets.com
Market Value: $155,714,862 a/o Jul 22, 2014
Shares Outstanding: 22,437,300 a/o May 14, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$LBIO extra dd links
Company name: Lion Biotechnologies, Inc.
Company website: http://www.lionbio.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=LBIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=LBIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=LBIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/news - http://finance.yahoo.com/q/h?s=LBIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/LBIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=LBIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/LBIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Lion+Biotechnologies%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Lion+Biotechnologies%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Lion+Biotechnologies%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.lionbio.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.lionbio.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.lionbio.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/LBIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001425205&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=LBIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=LBIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=LBIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=LBIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=LBIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=LBIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=LBIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/LBIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=LBIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/LBIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=LBIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/LBIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/LBIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/LBIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/LBIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/LBIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=LBIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=LBIO
$LBIO DD Notes ~ http://www.ddnotesmaker.com/LBIO
jkflb
Singh has already led Lion's stock to gains of nearly 100%!
In just a couple months Singh has already increased average volume 10-fold -- he has raised enough cash to operate for two years -- and produced large gains for shareholders.
In 2014, an uplisting to the NASDAQ will be a top priority. This means new investors, higher volume, and larger gains.
LBIO has $20 written all over it.
This was down 38% at one point today, but looking at Data Tools/Trades, not one share was sold today? Very strange.
So much for forward guidance. They planned on raising $10M in Q4 but raised $23M. So instead of 13.3% dilution, we have 30.6%. I'll wait to buy it at $2.00 too.
I was hoping the new ticker symbol would be "ROAR", or maybe "MEOW". :)
Thanks, Renee.
GNBPD changed to LBIO:
http://www.otcbb.com/asp/dailylist_detail.asp?d=10/22/2013&mkt_ctg=NON-OTCBB
Dilution should happen soon according to the company presentation (Q4 2013). In it they mention raising $10m gross and listed a market cap of $75m, so that would be 13.3% dilution or a little over 2m shares. That would price the offering at about $5.00/share, unless they needed to add a discount to complete the offering if not fully subscribed.
I used to own stock in IMUC under Singh
I had shares in IMUC when CEO Manish Singh was there. He did amazing things for that company and looking forward to what will transpire with LION. Now that the Genesis/ Lion merger is complete, expect great things here.
I'd expect dilution soon with only $500k in the kitty.
Anyone know anything that was said at the conference?
NEW TICKER--- *** GNBPD ***
Heed the new ticker. Expect major things to come along with Lion Biotechnologies. Dr. Manish Singh elevated IMUC to new levels and will do the same with Lion. Buy now right after the reverse split, because the price will skyrocket soon.
Lion in now over $5.00 PPS
The company is now realistically priced. The exposure it will now receive and the impending up-listing is a tremendous boon to the growth of the firm.
Reverse Split Important for Further Development!
This R/S will be great for the company. It needs to up its share price in this way to be considered more seriously by NASDAQ and institutional investors.
Strong Buy.
Genesis Biopharma Inc. changed to Lion Biotechnologies, Inc. and a one for 100 reverse split:
http://www.otcbb.com/asp/dailylist_detail.asp?d=09/25/2013&mkt_ctg=NON-OTCBB
PRE14C: Reverse Split~ Ratio in the range 1-for-50 and 1-for-100
(1) to effect, at the discretion of our Board, a reverse stock split (pro-rata reduction of outstanding shares) of Common Stock at a reverse split ratio in the range of between 1-for-50 and 1-for-100 (the “Reverse Stock Split”), which specific ratio will be determined by the Chairman of our Board prior to filing the Restated Articles (as defined below);
(2) to fix the number of authorized shares of Common Stock after the Reverse Stock Split at one hundred and fifty million (150,000,000) shares of Common Stock (the “Common Stock Increase”), which change will result in an increase in the authorized number of shares of Common Stock;
(3) to authorize the issuance of fifty million (50,000,000) shares of “blank check” preferred stock, $0.001 par value per share (the “Preferred Stock”), to be issued in series, and all properties of such Preferred Stock to be determined by the Company’s Board (the “Preferred Stock Authorization”);
(4) to change the name of the Company to “Lion Biotechnologies, Inc.” (the “Name Change”);
(5) to amend the Company’s Articles of Incorporation to add indemnification and limit the personal liability of officers and members of our Board (the “Indemnification”); and
(6) to approve an amendment to our 2011 stock option plan (a) increasing the number of shares of Common Stock authorized for issuance under the Genesis Biopharma, Inc. 2011 Equity Incentive Plan (the “Option Plan”) from 18,000,000 shares of Common Stock to 170,000,000 shares of Common Stock (prior to giving effect to the Reverse Stock Split), (b) increasing the maximum number of shares eligible for issuance under the Option Plan in any twelve-month period from 5,000,000 shares of Common Stock to 30,000,000 shares of Common Stock (prior to giving effect to the Reverse Stock Split) and (c) changing the name of the Option Plan to reflect the Name Change (collectively, the “Option Plan Amendment”).
www.sec.gov/Archives/edgar/data/1425205/000151316013000046/gnbpsc14c.htm
~
I would agree with Kris and Bob about post R/S consolidation, but it seems a lot of companies also complete some form of funding right after r/s as well. I think the hire of Singh is great long term but agree some things need to unwind.
Bob et all, FWIW, Dr. Jay Venkatesan is a very reputed Hedge Fund investor with stellar background and integrity. If he is drawn to the BOD, then he is seeing something special in Genesis.
Like Bob said, I am also waiting to add more once the R/S consolidation settles down.
Meanwhile not sure how many shares my 100K current holding will get converted to. 1:50 to 1:100 is a wide range.
Thanks for your opinion! I appreciate it!
for me, yes.
a gamble based on singhs track record.
nothing more.
gl
Yes I agree it's defiantly a great hire but is that enough reason to gain entry at this low point in your eyes?
Still researching and trying to figure out the long term prospects.
But the hire of Manish Singh is worthy enough to dabble after things settle down post RS for an intermediate play.
Gl
Followers
|
13
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1282
|
Created
|
03/17/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |